ePRO/eCOA White Papers & Case Studies
-
A Guide To Digital Endpoints In Major Depressive Disorder
3/7/2025
The integration of digital health technologies (DHTs) in clinical trials for Major Depressive Disorder (MDD) is transforming how symptom severity and treatment efficacy are measured.
-
The Evolution Of Technology For Safety Notifications
3/6/2025
Discover how a digital-first approach empowers sponsors to optimize safety management and drive operational efficiency in an increasingly complex, global clinical landscape.
-
Supporting Study Set Up In Just 4 To 6 Weeks
3/4/2025
Facing challenges in cycle times, quality control, and visibility, a global CRO adopted Medidata’s Rave Imaging, integrating it with its existing Rave EDC system to create a seamless digital workflow.
-
Biotech Delivers A Superior Patient And Site Experience
3/4/2025
To become the sponsor of choice for sites and patients in congenital hyperinsulinism clinical trials, a small biotech company prioritized delivering a superior experience while streamlining operations.
-
Accelerate Study Startup Through Better Collaboration
3/3/2025
With 80% of trials failing to enroll patients on time, improved collaboration between sites and sponsors is essential.
-
Evaluating Cognitive Safety In Clinical Trials
2/21/2025
Understanding cognitive function is essential in drug development. Explore how you can utilize cognitive tests to evaluate treatment effects on cognition with unrivaled accuracy and sensitivity.
-
Proactive COA Data Quality With PureSignal Analytics
2/21/2025
This blinded data analytics solution helps identify and mitigate COA data quality issues before they impact signal detection — optimizing rater reliability and scoring consistency.
-
Modernizing Clinical Research Through Digital Transformation
2/7/2025
Facilitate continuous, high-precision patient-centered data collection with a transformative digital health solution that enhances clinical research through its unified software and data ecosystem.
-
Medable Beats Forecasted FPI Date While Raising eCOA Adherence In Japan
2/7/2025
A top-10 global pharmaceutical company aimed to address eCOA adherence and patient enrollment challenges faced by clinical trial sites and participants in Japan. See how they accomplished it and more with this case study.
-
6 Key Ways Real-World Data Is Accelerating Breast Cancer Therapies
2/3/2025
Real-world data (RWD) is increasingly vital for advancing breast cancer research, and leveraging TA datasets allows researchers and clinicians to address pressing challenges.